Compare
Vivos Inc vs Family Office of America, Inc. vs QTREX Quantum Ltd. vs Pulse Biosciences, Inc.
| Latest fiscal year | Vivos Inc RDGL | Family Office of America, Inc. FOFA | QTREX Quantum Ltd. QTEX | Pulse Biosciences, Inc. PLSE |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $68.4K | $221.8K | $289.0K | $350.0K |
| Revenue growth (YoY) | +144.3% | n/a | n/a | n/a |
| Gross margin | -87.4% | 100.0% | 0.7% | -54.0% (computed) |
| Operating margin | n/m | -226.0% | n/m | n/m |
| Net margin | n/m | -222.2% | n/m | n/m |
| Net income | -$3.07M | -$492.7K | -$13.22M | -$72.78M |
| EPS (Diluted) | -$0.01 | -$0.02 | -$0.45 | n/a |
| Operating cash flow | -$2.06M | -$262.2K | -$9.86M | -$54.12M |
| Free cash flow | -$2.16M | n/a | -$9.96M | -$54.44M |
| Cash & equivalents | n/a | n/a | $3.16M | $80.73M |
| Total assets | $1.87M | $1.54M | $5.34M | $94.54M |
| Total liabilities | $206.7K | $878.5K | n/a | $13.88M |
| Shareholders' equity | $1.66M | $664.5K | $2.32M | $80.66M |
| Return on year-end equity | -184.6% | -74.2% | -569.1% | -90.2% |
| Shares outstanding | 455.49M | 30.20M | 35.95M | 67.84M |
Revenue, most recent five fiscal years
| Fiscal year | Vivos Inc | Family Office of America, Inc. | QTREX Quantum Ltd. | Pulse Biosciences, Inc. |
|---|---|---|---|---|
| Latest | $68.4K Ended 2025-12-31 | $221.8K Ended 2025-12-31 | $289.0K Ended 2025-12-31 | $350.0K Ended 2025-12-31 |
| 1 year earlier | $28.0K Ended 2024-12-31 | n/a | $0 Ended 2024-12-31 | $0 Ended 2024-12-31 |
| 2 years earlier | $19.5K Ended 2023-12-31 | n/a | $0 Ended 2023-12-31 | $0 Ended 2023-12-31 |
| 3 years earlier | $36.5K Ended 2022-12-31 | n/a | n/a | $700.0K Ended 2022-12-31 |
| 4 years earlier | $14.9K Ended 2021-12-31 | n/a | n/a | $1.42M Ended 2021-12-31 |